REFERENCES
- Henderson DK, Gillespie RD. Textbook of Psychiatry. Oxford: Oxford University Press, 1937.
- Schiffer RB, Klein RF, Sider RC. The Medical Evaluation of Psychiatric Patients. London, New York: Plenum Publishing, 1988.
- Richter D. The biological investigation of schizophrenia-academic address. Biol Psychiat 1970; 2: 153–64.
- Cott A. Controlled fasting treatment of schizophrenia in the U SSR. Schizophrenia 1971; 3: 2–10.
- Dohan FC. Schizophrenia: possible relationship to cereal grains and coeliac disease. In: Sanker S ed. Schizophrenia Current Concepts and Research. Hicksville, NY: PJD Publications, 1969, pp. 539–51.
- Dohan FC. Schizophrenia. A re some food-derived polypeptides pathogenic? Coeliac disease as a model. In: Hemmings GP , Hemmings WA eds. Biological Basis of Schizophrenia. Lancaster: MTP Press, 1978, pp. 167–77.
- Buscaino GA. The am ino-hepatoenterotoxic theory of schizophrenia: an historical evaluation. In: Hemmings GP Hemmings WA eds. Biological Basis of Schizophrenia. Lancaster: MTP Press, 1978, pp. 45–54.
- Baruk H. Psychoses of digestive origins. In: Hemmings , Hemmings WA eds. Biological Basis of Schizophrenia. Lancaster: MTP Press, 1978, pp. 37–44.
- Horrobin D F, Glen A M, Vaddadi K. The membrane hypothesis of schizophrenia. Schizophrenia Res 1994;13:195–207.
- Hudson CJ, K ennedy JL, G otowiec A, et al. Genetic Variant N ear Cytosolic Phospholipase A2 Associated W ith Schizophrenia. Schizophrenia Res 1996; 21: 111–16.
- Peck M P. Interaction of lipids with immune function. Biochemical effects of dietary lipids on plasma membranes J Nutr Biochem 1994; 5: 466–77.
- Coryell W. No details supplied.
- Holden RJ, Mooney RA. Schizophrenia is a diabetic brain state: an elucidation of im paired neu- rom etabolism. Med H ypotheses 1994; 43: 420–35.
- Reading C. Your Family Tree Connection. Connecticut: K eats Publishing Company, 1988.
- Seelig MS. Cardiovascular consequences of magnesium de flciency. A m J Cardiol 1989; 13: 195–207.
- Kerov G.K. et al. Magnesium, schizophrenia and manic depressive disease. N europsychobiology 1990;23:79–81.
- Le Duc PA, M ittelm an G. Schizophrenia and psychostimulant abuse: a review and reanalysis of clinical evidence. Psychopharmacology 1995; 121: 407–27.